Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain

Journal of Neurochemistry

Volumn 134, Issue 3, 2015, Pages 471-485

  González De San Román, Estibaliz ^a   Manuel, Iván ^a   Giralt, María Teresa ^a   Chun, Jerold ^b   Estivill Torrús, Guillermo ^c   Rodríguez De Fonseca, Fernando ^c   Santín, Luis Javier ^c   Ferrer, Isidro ^d   Rodríguez Puertas, Rafael ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c Institute of Biomedical Research in Malaga and BIONAND Nanomedicine Platform   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

brain; G protein coupled receptor; imaging mass spectrometry; lysophosphatidic acid; rodent and human; 35S GTP S

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID 1 RECEPTOR; LYSOPHOSPHATIDIC ACID PHOSPHOLIPID PRECURSOR; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SULFUR 35; UNCLASSIFIED DRUG; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHOLIPID;

ADULT; AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CAPSULA INTERNA; CEREBELLUM; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; FRONTAL CORTEX; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION IMAGING MASS SPECTROMETRY; MIDDLE AGED; MOUSE; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; BRAIN CHEMISTRY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

MUS; RATTUS; RODENTIA;

ANIMALS; AUTORADIOGRAPHY; BRAIN; BRAIN CHEMISTRY; HUMANS; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, KNOCKOUT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LYSOPHOSPHATIDIC ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84935454672     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13112     Document Type: Article

References (90)

1. Aaltonen N., Palomaki V. A., Lecklin A., and, Laitinen J. T., (2008) Neuroanatomical mapping of juvenile rat brain regions with prominent basal signal in [(35)S]GTPgammaS autoradiography. J. Chem. Neuroanat. 35, 233-241.
2. Aaltonen N., Lehtonen M., Varonen K., Goterris G. A., and, Laitinen J. T., (2012) Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradation. BMC Pharmacol. 12, 1-14.
3. Allard J., Barron S., Trottier S., Cervera P., Daumas-Duport C., Leguern E., Brice A., Schwartz J. C., and, Sokoloff P., (1999) Edg-2 in myelin-forming cells: isoforms, genomic mapping, and exclusion in Charcot-Marie-Tooth disease. Glia 26, 176-185.
4. An S., Goetzl E. J., and, Lee H., (1998) Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. J. Cell. Biochem. Suppl. 30-31, 147-157.
5. Aoki J., (2004) Mechanisms of lysophosphatidic acid production. Semin. Cell Dev. Biol. 15, 477-489.
6. Aoki J., Inoue A., and, Okudaira S., (2008) Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta 1781, 513-518.
7. Astigarraga E., Barreda-Gõmez G., Lombardero L., Fresnedo O., Castaño F., Giralt M. T., Ochoa B., Rodríguez-Puertas R., and, Fernández J. A., (2008) Profiling and imaging of lipids on brain and liver tissue by matrix-assisted laser desorption/ionization mass spectrometry using 2-mercaptobenzothiazole as a matrix. Anal. Chem. 80, 9105-9114.
8. Bandoh K., Aoki J., Hosono H., Kobayashi S., Kobayashi T., Murakami-Murofushi K., Tsujimoto M., Arai H., and, Inoue K., (1999) Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 274, 27776-27785.
9. Bandoh K., Aoki J., Taira A., Tsujimoto M., Arai H., and, Inoue K., (2000) Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett. 478, 159-165.
10. Barreda-Gõmez G., Giralt M. T., Pazos A., and, Rodriguez-Puertas R., (2014) Galanin activated G-proteins in human and rat central nervous systems. Neuropeptides 48, 295-304.
11. Bishop W. R., and, Bell R. M., (1988) Assembly of phospholipids into cellular membranes: biosynthesis, transmembrane movement and intracellular translocation. Annu. Rev. Cell Biol. 4, 579-610.
12. Caprioli R. M., Farmer T. B., and, Gile J., (1997) Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal. Chem. 69, 4751-4760.
13. Castilla-Ortega E., Escuredo L., Bilbao A., Pedraza C., Orio L., Estivill-Torrús G., Santín L. J., De Fonseca F. R., and, Pavõn F. J., (2014) 1-Oleoyl lysophosphatidic acid: a new mediator of emotional behavior in rats. PLoS ONE 9, e85348.
14. Choi J. W., and, Chun J., (2013) Lysophospholipids and their receptors in the central nervous system. Biochim. Biophys. Acta 1831, 20-32.
15. Chun J., (1999) Lysophospholipid receptors: implications for neural signaling. Crit. Rev. Neurobiol. 13, 151-168.
16. Chun J., Weiner J. A., Fukushima N., et al,. (2000) Neurobiology of receptor-mediated lysophospholipid signaling. From the first lysophospholipid receptor to roles in nervous system function and development. Ann. N. Y. Acad. Sci. 905, 110-117.
17. Contos J. J., Ishii I., and, Chun J., (2000) Lysophosphatidic acid receptors. Mol. Pharmacol. 58, 1188-1196.
18. Das A. K., and, Hajra A. K., (1989) Quantification, characterization and fatty acid composition of lysophosphatidic acid in different rat tissues. Lipids 24, 329-333.
19. Dubin A. E., Herr D. R., and, Chun J., (2010) Diversity of lysophosphatidic acid receptor-mediated intracellular calcium signaling in early cortical neurogenesis. J. Neurosci. 30, 7300-7309.
20. Erickson J. R., Wu J. J., Goddard J. G., Tigyi G., Kawanishi K., Tomei L. D., and, Kiefer M. C., (1998) Edg-2/Vzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acid. J. Biol. Chem. 273, 1506-1510.
21. Estivill-Torrús G., Llebrez-Zayas P., Matas-Rico E., Santin L., Pedraza C., De Diego I., Del Arco I., Fernandez-Llebrez P., Chun J., and, de Fonseca F. R., (2008) Absence of LPA1 signaling results in defective cortical development. Cereb. Cortex 18, 938-950.
22. Fernández J. A., Ochoa B., Fresnedo O., Giralt M. T., and, Rodriguez-Puertas R., (2011) Matrix-assisted laser desorption ionization imaging mass spectrometry in lipidomics. Anal. Bioanal. Chem. 401, 29-51.
23. Fischer D. J., Liliom K., Guo Z., et al,. (1998) Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes. Mol. Pharmacol. 54, 979-988.
24. Foster D. A., (2013) Phosphatidic acid and lipid-sensing by mTOR. Trends Endocrinol. Metab. 24, 272-278.
25. Fourcade O., Simon M. F., Viode C., Rugani N., Leballe F., Ragab A., Fournie B., Sarda L., and, Chap H., (1995) Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80, 919-927.
26. Fukushima N., (2004) LPA in neural cell development. J. Cell. Biochem. 92, 993-1003.
27. Fukushima N., Kimura Y., and, Chun J., (1998) A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc. Natl Acad. Sci. USA 95, 6151-6156.
28. Fukushima N., Weiner J. A., and, Chun J., (2000) Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology. Dev. Biol. 228, 6-18.
29. Fukushima N., Ishii I., Contos J. J., Weiner J. A., and, Chun J., (2001) Lysophospholipid receptors. Annu. Rev. Pharmacol. Toxicol. 41, 507-534.
30. Fukushima N., Ye X., and, Chun J., (2002) Neurobiology of lysophosphatidic acid signaling. Neuroscientist 8, 540-550.
31. Gaits F., Fourcade O., Le Balle F., et al,. (1997) Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis. FEBS Lett. 410, 54-58.
32. García-Díaz B., Riquelme R., Varela-Nieto I., et al,. (2014) Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex. Brain Struct. Funct. doi: 10.1007/s00429-014-0885-7 [Epub ahead of print].
33. Gerrard J. M., and, Robinson P., (1989) Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim. Biophys. Acta 1001, 282-285.
34. Goetzl E. J., and, An S., (1998) Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 12, 1589-1598.
35. González-Maeso J., Torre I., Rodriguez-Puertas R., Garcia-Sevilla J. A., Guimon J., and, Meana J. J., (2002) Effects of age, postmortem delay and storage time on receptor-mediated activation of G-proteins in human brain. Neuropsychopharmacology 26, 468-478.
36. Grove K. J., Voziyan P. A., Spraggins J. M., Wang S., Paueksakon P., Harris R. C., Hudson B. G., and, Caprioli R. M., (2014) Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles. J. Lipid Res. 55, 1375-1385.
37. Happe H. K., Bylund D. B., and, Murrin L. C., (2000) Alpha(2)-adrenoceptor-stimulated GTP gamma S binding in rat brain: an autoradiographic study. Eur. J. Pharmacol. 399, 17-27.
38. 35S]GTPgammaS binding assay: approaches and applications in pharmacology. Life Sci. 74, 489-508.
39. Harrison S. M., Reavill C., Brown G., et al,. (2003) LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease. Mol. Cell Neurosci. 24, 1170-1179.
40. Hayashi K., Takahashi M., Nishida W., Yoshida K., Ohkawa Y., Kitabatake A., Aoki J., Arai H., and, Sobue K., (2001) Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ. Res. 89, 251-258.
41. Hecht J. H., Weiner J. A., Post S. R., and, Chun J., (1996) Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135, 1071-1083.
42. Herr K. J., Herr D. R., Lee C. W., Noguchi K., and, Chun J., (2011) Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling. Proc. Natl Acad. Sci. USA 108, 15444-15449.
43. Hiramatsu T., Sonoda H., Takanezawa Y., Morikawa R., Ishida M., Kasahara K., Sanai Y., Taguchi R., Aoki J., and, Arai H., (2003) Biochemical and molecular characterization of two phosphatidic acid-selective phospholipase A1s, mPA-PLA1alpha and mPA-PLA1beta. J. Biol. Chem. 278, 49438-49447.
44. Inoue M., Rashid M. H., Fujita R., Contos J. J., Chun J., and, Ueda H., (2004) Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat. Med. 10, 712-718.
45. Ishii I., Contos J. J., Fukushima N., and, Chun J., (2000) Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol. Pharmacol. 58, 895-902.
46. Ishii I., Fukushima N., Ye X., and, Chun J., (2004) Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 73, 321-354.
47. Jalink K., Eichholtz T., Postma F. R., van Corven E. J., and, Moolenaar W. H., (1993) Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action. Cell Growth Differ. 4, 247-255.
48. Jalink K., Hengeveld T., Mulder S., Postma F. R., Simon M. F., Chap H., van der Marel G. A., van Boom J. H., van Blitterswijk W. J., and, Moolenaar W. H., (1995) Lysophosphatidic acid-induced Ca2 + mobilization in human A431 cells: structure-activity analysis. Biochem. J. 307 (Pt 2), 609-616.
49. Kihara Y., Maceyka M., Spiegel S., and, Chun J., (2014) Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br. J. Pharmacol. 171, 3575-3594.
50. Kingsbury M. A., Rehen S. K., Contos J. J., Higgins C. M., and, Chun J., (2003) Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. Nat. Neurosci. 6, 1292-1299.
51. Kotarsky K., Boketoft A., Bristulf J., Nilsson N. E., Norberg A., Hansson S., Owman C., Sillard R., Leeb-Lundberg L. M., and, Olde B., (2006) Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J. Pharmacol. Exp. Ther. 318, 619-628.
52. Kranenburg O., Poland M., van Horck F. P., Drechsel D., Hall A., and, Moolenaar W. H., (1999) Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction. Mol. Biol. Cell 10, 1851-1857.
53. 35S]guanosine 5'-(gamma-thio)triphosphate autoradiography. Neuroscience 90, 1265-1279.
54. Lee H., Goetzl E. J., and, An S., (2000) Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am. J. Physiol. Cell Physiol. 278, C612-C618.
55. Matas-Rico E., Garcia-Diaz B., Llebrez-Zayas P., et al,. (2008) Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus. Mol. Cell Neurosci. 39, 342-355.
56. Moller T., Musante D. B., and, Ransom B. R., (1999) Lysophosphatidic acid-induced calcium signals in cultured rat oligodendrocytes. NeuroReport 10, 2929-2932.
57. Moller T., Contos J. J., Musante D. B., Chun J., and, Ransom B. R., (2001) Expression and function of lysophosphatidic acid receptors in cultured rodent microglial cells. J. Biol. Chem. 276, 25946-25952.
58. Moore R. J., Xiao R., Sim-Selley L. J., and, Childers S. R., (2000) Agonist-stimulated [35S]GTPgammaS binding in brain modulation by endogenous adenosine. Neuropharmacology 39, 282-289.
59. Noguchi K., Ishii S., and, Shimizu T., (2003) Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 278, 25600-25606.
60. Palomaki V. A., and, Laitinen J. T., (2006) The basic secretagogue compound 48/80 activates G proteins indirectly via stimulation of phospholipase D-lysophosphatidic acid receptor axis and 5-HT1A receptors in rat brain sections. Br. J. Pharmacol. 147, 596-606.
61. Pedraza C., Sánchez-Lõpez J., Castilla-Ortega E., Rosell-Valle C., Zambrana-Infantes E., García-Fernández M., Rodriguez de Fonseca F., Chun J., Santín L. J., and, Estivill-Torrús G., (2014) Fear extinction and acute stress reactivity reveal a role of LPA(1) receptor in regulating emotional-like behaviors. Brain Struct. Funct. 219, 1659-1672.
62. Pieringer R. A., Bonner H., Jr, and, Kunnes R. S., (1967) Biosynthesis of phosphatidic acid, lysophosphatidic acid, diglyceride, and triglyceride by fatty acyltransferase pathways in Escherichia coli. J. Biol. Chem. 242, 2719-2724.
63. 1 in formation of synapses among cultured hippocampal neurons. J. Neurochem. 97, 1379-1392.
64. Rao T. S., Lariosa-Willingham K. D., Lin F. F., Palfreyman E. L., Yu N., Chun J., and, Webb M., (2003) Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes. Brain Res. 990, 182-194.
65. Renback K., Inoue M., Yoshida A., Nyberg F., and, Ueda H., (2000) Vzg-1/lysophosphatidic acid-receptor involved in peripheral pain transmission. Brain Res. Mol. Brain Res. 75, 350-354.
66. Rodríguez-Puertas R., González-Maeso J., Meana J. J., and, Pazos A., (2000) Autoradiography of receptor-activated G-proteins in post mortem human brain. Neuroscience 96, 169-180.
67. Schwartz S. A., Reyzer M. L., and, Caprioli R. M., (2003) Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. J. Mass Spectrom. 38, 699-708.
68. Shano S., Moriyama R., Chun J., and, Fukushima N., (2008) Lysophosphatidic acid stimulates astrocyte proliferation through LPA1. Neurochem. Int. 52, 216-220.
69. Sim L. J., Selley D. E., and, Childers S. R., (1995) In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding. Proc. Natl Acad. Sci. USA 92, 7242-7246.
70. 35S]GTP gamma S binding. Methods Mol. Biol. 83, 117-132.
71. Spohr T. C., Choi J. W., Gardell S. E., Herr D. R., Rehen S. K., Gomes F. C., and, Chun J., (2008) Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation. J. Biol. Chem. 283, 7470-7479.
72. Spohr T. C., Dezonne R. S., Rehen S. K., and, Gomes F. C., (2014) LPA-primed astrocytes induce axonal outgrowth of cortical progenitors by activating PKA signaling pathways and modulating extracellular matrix proteins. Front. Cell. Neurosci. 8, 296.
73. Sugiura T., Nakane S., Kishimoto S., Waku K., Yoshioka Y., Tokumura A., and, Hanahan D. J., (1999) Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells. Biochim. Biophys. Acta 1440, 194-204.
74. Sun Y., Kim N. H., Yang H., Kim S. H., and, Huh S. O., (2011) Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3beta activation. Mol. Cells 31, 483-489.
75. Tabuchi S., Kume K., Aihara M., and, Shimizu T., (2000) Expression of lysophosphatidic acid receptor in rat astrocytes: mitogenic effect and expression of neurotrophic genes. Neurochem. Res. 25, 573-582.
76. Tham C., Lin F., Rao T. S., Yu N., and, Webb M., (2003) Microglial activation state and lysophospholipid acid receptor expression. Int. J. Dev. Neurosci. 21, 431-443.
77. Tigyi G., and, Parrill A. L., (2003) Molecular mechanisms of lysophosphatidic acid action. Prog. Lipid Res. 42, 498-526.
78. Tigyi G., Hong L., Yakubu M., Parfenova H., Shibata M., and, Leffler C. W., (1995) Lysophosphatidic acid alters cerebrovascular reactivity in piglets. Am. J. Physiol. 268, H2048-H2055.
79. Tigyi G., Fischer D. J., Sebok A., Yang C., Dyer D. L., and, Miledi R., (1996) Lysophosphatidic acid-induced neurite retraction in PC12 cells: control by phosphoinositide-Ca2 + signaling and Rho. J. Neurochem. 66, 537-548.
80. Tokumura A., (1995) A family of phospholipid autacoids: occurrence, metabolism and bioactions. Prog. Lipid Res. 34, 151-184.
81. Tokumura A., Iimori M., Nishioka Y., Kitahara M., Sakashita M., and, Tanaka S., (1994) Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am. J. Physiol. 267, C204-C210.
82. Touboul D., Piednoel H., Voisin V., De La Porte S., Brunelle A., Halgand F., and, Laprevote O., (2004) Changes of phospholipid composition within the dystrophic muscle by matrix-assisted laser desorption/ionization mass spectrometry and mass spectrometry imaging. Eur. J. Mass Spectrom. (Chichester, Eng) 10, 657-664.
83. Weiner J. A., and, Chun J., (1999) Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. Proc. Natl Acad. Sci. USA 96, 5233-5238.
84. Weiner J. A., Hecht J. H., and, Chun J., (1998) Lysophosphatidic acid receptor gene vzg-1/lpA1/edg-2 is expressed by mature oligodendrocytes during myelination in the postnatal murine brain. J. Comp. Neurol. 398, 587-598.
85. Weiner J. A., Fukushima N., Contos J. J., Scherer S. S., and, Chun J., (2001) Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling. J. Neurosci. 21, 7069-7078.
86. Yang J., and, Caprioli R. M., (2011) Matrix sublimation/recrystallization for imaging proteins by mass spectrometry at high spatial resolution. Anal. Chem. 83, 5728-5734.
87. Ye X., Fukushima N., Kingsbury M. A., and, Chun J., (2002) Lysophosphatidic acid in neural signaling. NeuroReport 13, 2169-2175.
88. Yoshida K., Nishida W., Hayashi K., Ohkawa Y., Ogawa A., Aoki J., Arai H., and, Sobue K., (2003) Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 108, 1746-1752.
89. Yung Y. C., Mutoh T., Lin M. E., Noguchi K., Rivera R. R., Choi J. W., Kingsbury M. A., and, Chun J., (2011) Lysophosphatidic acid signaling may initiate fetal hydrocephalus. Sci. Transl. Med. 3, 99ra87.
90. Yung Y. C., Stoddard N. C., and, Chun J., (2014) LPA receptor signaling: pharmacology, physiology, and pathophysiology. J. Lipid Res. 55, 1192-1214.